Clinical trial Recruiting at 1 site Interventional Ages 18 to 44 Women only

Interactive support messaging for women with recurrent pregnancy loss

Official title: A Single-arm Trial of a Web Based TLC (Tender Loving Care) Platform to Psychologically Support Patients With Recurrent Pregnancy Loss

Run by Walter Reed National Military Medical Center · NCT06182878 · Data updated 2026-11-12

This study tests if a weekly messaging program that offers support and advice can help women who have had multiple pregnancy losses have healthier pregnancies and feel better overall.

Quick facts

Study typeInterventional
Ages18 Years to 44 Years
SexWomen only
Enrollment60 (estimated)
SponsorWalter Reed National Military Medical Center
Federal
Locations1 site (Bethesda, Maryland)
StatusRecruiting
StartedJanuary 1, 2024
Main results expectedDecember 1, 2026
Study endsDecember 1, 2026
Registry record updatedApril 22, 2026
Trial IDNCT06182878 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are pregnant individuals at less than or equal to 10 weeks gestation with a history of at least two prior pregnancy losses.

Probably not a fit

Patients with certain medical conditions, such as uterine anomalies or those who are current smokers, may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This investigational study evaluates the impact of a weekly interactive messaging platform designed to provide tender loving care on pregnancy outcomes for individuals experiencing recurrent pregnancy loss. Participants will engage with messages that offer prenatal counseling and support while completing a fertility quality of life survey throughout their pregnancy. The study aims to determine if this intervention can increase live birth rates, enhance quality of life, and reduce depressive symptoms among participants.

Why it matters

Potential benefit: If successful, this approach could improve live birth rates and overall well-being for patients with recurrent pregnancy loss.

How similar studies have gone: While the specific approach of interactive messaging for this condition is novel, similar supportive interventions have shown promise in improving outcomes in other patient populations.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Pregnant individuals receiving their prenatal care at WRNMMC
* Able to speak and understand English
* Less than or equal to 10+0 weeks gestation by last menstrual period (LMP) or dating ultrasound at the time of enrollment
* At least two prior pregnancy losses. Pregnancy losses must be confirmed with laboratory criteria confirming a positive pregnancy test in the military electronic medical record with subsequent resolution (resolution may be reported by patient), or with ultrasound criteria demonstrating an intrauterine gestational sac with subsequent resolution (resolution may be reported by patient).

Exclusion Criteria:

* Age less than 18 years and older than 44 at time of enrollment
* Unable to speak or understand English
* Current smoker or tobacco use within 30 days
* History of uterine anomaly, coagulopathy, balanced translocation, endometrial polyps, submucosal fibroids, pathology confirmed acute or chronic endometritis, hydrosalpinx, history of Asherman syndrome, poorly controlled endocrinopathies, HIV infection
* History of gonadotoxic therapy or cancerous condition of the female reproductive tract
* Suspicion for or confirmation of an ectopic pregnancy

Where it's running

  • Walter Reed National Military Medical Center
    Bethesda, Maryland, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.